Patent · US Active

Protein-antiviral compound conjugates

US11752214B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Alina BAUM · Pleasantville, US
Thomas Nittoli · Pearl River, US

Key dates

Filing date	Jan 23, 2021
Grant date	Sep 12, 2023
Priority date	—
Expiry date	Sep 10, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/6841
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with influenza, including VX-787 and derivatives thereof, baloxavir and derivatives thereof, and baloxavir marboxil and derivatives thereof, and protein (e.g., antibody) drug conjugates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.